Cargando…

Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate

BACKGROUND: Three groups of iris prostheses can be distinguished for the surgical treatment of iris defects: (1) segmental iris implants, (2) combined iris diaphragm intraocular lenses (IOL) and (3) pure iris implants. Most iris reconstructions are accompanied by aphakia correction with secondary IO...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, C., Scharf, D., Khoramnia, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813724/
https://www.ncbi.nlm.nih.gov/pubmed/34236489
http://dx.doi.org/10.1007/s00347-021-01447-9
_version_ 1784644923405893632
author Mayer, C.
Scharf, D.
Khoramnia, R.
author_facet Mayer, C.
Scharf, D.
Khoramnia, R.
author_sort Mayer, C.
collection PubMed
description BACKGROUND: Three groups of iris prostheses can be distinguished for the surgical treatment of iris defects: (1) segmental iris implants, (2) combined iris diaphragm intraocular lenses (IOL) and (3) pure iris implants. Most iris reconstructions are accompanied by aphakia correction with secondary IOL implantation. Although the primary goal is to create a pupil and to improve glare perception, contrast sensitivity and visual acuity, the esthetic result is also a relevant component. OBJECTIVE: Functional and esthetic results after replacement of an aniridia IOL implant with a custom-made artificial iris with IOL. MATERIAL AND METHODS: In this retrospective study with seven eyes from seven patients, an iris diaphragm IOL (Morcher GmbH, Stuttgart, Germany) was exchanged for medical reasons (subluxation) against a custom-made artificial iris made of silicone (ArtificialIris, HumanOptics, Erlangen, Germany) in combination with a sutured IOL. The follow-up period was at least 3 months. Best corrected distance visual acuity (BCVA), endothelial cell count (ECC), complications, glare perception as well as esthetic outcome and patient satisfaction were evaluated. RESULTS: The BCVA and ECC showed no statistically significant change between the preoperative and postoperative values (p > 0.05). There was a decentration of the iris IOL implant of 0.27 ± 0.19 mm three months postoperatively. On a visual analogue scale (VAS) from 1 to 10 (1 = not satisfied at all, 10 = extremely satisfied), satisfaction with the overall result was rated 8.6 ± 2.5. Subjective glare perception improved to 5.6 ± 3.5 and subjective esthetic impairment improved to 2.4 ± 2.0 on the VAS (1 = none, 10 = extremely strong). Postoperative complications included transient intraocular hypotonia in two eyes, intraocular pressure increase in two eyes, retinal detachment and transient vitreous hemorrhage in one eye each. Of the seven patients six would repeat the procedure. CONCLUSION: Compared to a rigid aniridia IOL implant, replacement with a custom-made artificial iris in combination with an IOL provides not only a good functional result but simultaneously also an esthetically pleasing result.
format Online
Article
Text
id pubmed-8813724
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-88137242022-02-14 Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate Mayer, C. Scharf, D. Khoramnia, R. Ophthalmologe Originalien BACKGROUND: Three groups of iris prostheses can be distinguished for the surgical treatment of iris defects: (1) segmental iris implants, (2) combined iris diaphragm intraocular lenses (IOL) and (3) pure iris implants. Most iris reconstructions are accompanied by aphakia correction with secondary IOL implantation. Although the primary goal is to create a pupil and to improve glare perception, contrast sensitivity and visual acuity, the esthetic result is also a relevant component. OBJECTIVE: Functional and esthetic results after replacement of an aniridia IOL implant with a custom-made artificial iris with IOL. MATERIAL AND METHODS: In this retrospective study with seven eyes from seven patients, an iris diaphragm IOL (Morcher GmbH, Stuttgart, Germany) was exchanged for medical reasons (subluxation) against a custom-made artificial iris made of silicone (ArtificialIris, HumanOptics, Erlangen, Germany) in combination with a sutured IOL. The follow-up period was at least 3 months. Best corrected distance visual acuity (BCVA), endothelial cell count (ECC), complications, glare perception as well as esthetic outcome and patient satisfaction were evaluated. RESULTS: The BCVA and ECC showed no statistically significant change between the preoperative and postoperative values (p > 0.05). There was a decentration of the iris IOL implant of 0.27 ± 0.19 mm three months postoperatively. On a visual analogue scale (VAS) from 1 to 10 (1 = not satisfied at all, 10 = extremely satisfied), satisfaction with the overall result was rated 8.6 ± 2.5. Subjective glare perception improved to 5.6 ± 3.5 and subjective esthetic impairment improved to 2.4 ± 2.0 on the VAS (1 = none, 10 = extremely strong). Postoperative complications included transient intraocular hypotonia in two eyes, intraocular pressure increase in two eyes, retinal detachment and transient vitreous hemorrhage in one eye each. Of the seven patients six would repeat the procedure. CONCLUSION: Compared to a rigid aniridia IOL implant, replacement with a custom-made artificial iris in combination with an IOL provides not only a good functional result but simultaneously also an esthetically pleasing result. Springer Medizin 2021-07-08 2022 /pmc/articles/PMC8813724/ /pubmed/34236489 http://dx.doi.org/10.1007/s00347-021-01447-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Originalien
Mayer, C.
Scharf, D.
Khoramnia, R.
Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate
title Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate
title_full Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate
title_fullStr Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate
title_full_unstemmed Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate
title_short Austausch von Aniridie-IOL gegen individuelle Iris-IOL-Implantate
title_sort austausch von aniridie-iol gegen individuelle iris-iol-implantate
topic Originalien
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813724/
https://www.ncbi.nlm.nih.gov/pubmed/34236489
http://dx.doi.org/10.1007/s00347-021-01447-9
work_keys_str_mv AT mayerc austauschvonaniridieiolgegenindividuelleirisiolimplantate
AT scharfd austauschvonaniridieiolgegenindividuelleirisiolimplantate
AT khoramniar austauschvonaniridieiolgegenindividuelleirisiolimplantate